{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49,
    68,
    69,
    70,
    71,
    72,
    135,
    73,
    75,
    76,
    77,
    79,
    81,
    82,
    84,
    87,
    88,
    89,
    90,
    93,
    95
  ],
  "modelUsed": "gemini-3-flash-preview",
  "data": {
    "timeAnchors": [],
    "repetitions": [],
    "samplingConstraints": [],
    "traversalConstraints": [
      {
        "id": "traversal_1",
        "requiredSequence": [
          "SCREENING",
          "OPEN_LABEL_RUN_IN",
          "RANDOMIZED_BLINDED_TREATMENT",
          "END_OF_TREATMENT",
          "END_OF_STUDY"
        ],
        "allowEarlyExit": true,
        "exitEpochIds": [
          "EARLY_TERMINATION"
        ],
        "mandatoryVisits": [
          "Screening",
          "End of Treatment",
          "Week 12",
          "End of Study"
        ],
        "sourceText": "[{'condition': 'Subject experiences a flare during the blinded treatment period', 'path': ['RESCUE_TREATMENT', 'RESCUE_WEEK_0', 'RESCUE_WEEK_8', 'RESCUE_WEEK_12', 'RESCUE_WEEK_16']}, {'condition': 'Subject in high-risk TB region (>10/100,000 prevalence)', 'path': ['ONE_YEAR_TB_RETEST']}, {'condition': 'Subject is HBsAg negative and HBcAb positive at screening', 'path': ['HBV_DNA_MONITORING_WEEK_12', 'HBV_DNA_MONITORING_WEEK_28', 'HBV_DNA_MONITORING_WEEK_40', 'HBV_DNA_MONITORING_WEEK_52']}, {'condition': 'HBV DNA result above Lower Limit of Quantification (LLQ)', 'path': ['IMMEDIATE_PERMANENT_DISCONTINUATION']}]"
      }
    ],
    "executionTypes": [
      {
        "activityId": "Pe",
        "executionType": "Single",
        "rationale": "No strong signals detected"
      },
      {
        "activityId": "Ae",
        "executionType": "Single",
        "rationale": "No strong signals detected"
      },
      {
        "activityId": "C-SSRS (Columbia Suicide Severity Rating Scale)",
        "executionType": "Single",
        "rationale": "Administered at all remaining scheduled visits in Run In, Blinded treatments, and specific Rescue weeks."
      },
      {
        "activityId": "Hepatitis B surface antigen (HBsAg) testing",
        "executionType": "Single",
        "rationale": "Performed at Screening to determine eligibility."
      },
      {
        "activityId": "HBV DNA reflex testing",
        "executionType": "Single",
        "rationale": "Conditional workflow triggered only if subject is HBsAg negative, HBcAb positive, and HBsAb positive at screening."
      },
      {
        "activityId": "HBV DNA monitoring",
        "executionType": "Single",
        "rationale": "Repeated at specific intervals (Weeks 12, 28, 40, 52, etc.) for a specific subset of enrolled subjects."
      },
      {
        "activityId": "Treatment Discontinuation",
        "executionType": "Single",
        "rationale": "Immediate and permanent discontinuation is triggered by a single HBV DNA test result above the LLQ."
      },
      {
        "activityId": "PK sample collection",
        "executionType": "Single",
        "rationale": "Collected at current PK sample time points for metabolite analysis."
      }
    ],
    "footnoteConditions": [
      {
        "id": "fn_cond_1",
        "conditionType": "general",
        "text": "a. Day -28 Screening",
        "footnoteId": "fn_1",
        "structuredCondition": "visit.day == -28",
        "appliesToActivityIds": [
          "Screening"
        ],
        "sourceText": "a. Day -28 Screening"
      },
      {
        "id": "fn_cond_2",
        "conditionType": "general",
        "text": "b. Specific visits for responders or specific day markers",
        "footnoteId": "fn_2",
        "structuredCondition": "subject.status == \"responder\" || visit.marker == \"specific\"",
        "appliesToActivityIds": [
          "Specific visits"
        ],
        "sourceText": "b. Specific visits for responders or specific day markers"
      },
      {
        "id": "fn_cond_3",
        "conditionType": "timing_before",
        "text": "c. Informed consent must be obtained before any study-specific procedures",
        "footnoteId": "fn_3",
        "structuredCondition": "activity(ICF).status == \"completed\" BEFORE activity(ANY)",
        "appliesToActivityIds": [
          "All study-specific procedures"
        ],
        "sourceText": "c. Informed consent must be obtained before any study-specific procedures"
      },
      {
        "id": "fn_cond_4",
        "conditionType": "general",
        "text": "d. C-SSRS, SBQ-R, and PHQ-8 are suicidality and mood assessments",
        "footnoteId": "fn_4",
        "structuredCondition": "assessment.group == [\"C-SSRS\", \"SBQ-R\", \"PHQ-8\"]",
        "appliesToActivityIds": [
          "Suicidality assessments",
          "Mood assessments"
        ],
        "sourceText": "d. C-SSRS, SBQ-R, and PHQ-8 are suicidality and mood assessments"
      },
      {
        "id": "fn_cond_5",
        "conditionType": "general",
        "text": "e. Disease history includes Atopic Dermatitis specific details",
        "footnoteId": "fn_5",
        "structuredCondition": "history.type == \"Atopic Dermatitis\"",
        "appliesToActivityIds": [
          "Disease history"
        ],
        "sourceText": "e. Disease history includes Atopic Dermatitis specific details"
      },
      {
        "id": "fn_cond_6",
        "conditionType": "general",
        "text": "g. Vital signs include blood pressure, pulse, respiratory rate, and temperature",
        "footnoteId": "fn_7",
        "structuredCondition": "vitals.components == [\"BP\", \"Pulse\", \"RR\", \"Temp\"]",
        "appliesToActivityIds": [
          "Vital signs"
        ],
        "sourceText": "g. Vital signs include blood pressure, pulse, respiratory rate, and temperature"
      },
      {
        "id": "fn_cond_7",
        "conditionType": "procedure_fasting",
        "text": "h. Laboratory assessments require specific fasting or conditions",
        "footnoteId": "fn_8",
        "structuredCondition": "subject.isFasting == true",
        "appliesToActivityIds": [
          "Laboratory assessments"
        ],
        "sourceText": "h. Laboratory assessments require specific fasting or conditions"
      },
      {
        "id": "fn_cond_8",
        "conditionType": "general",
        "text": "i. Hematology includes CBC and differentials",
        "footnoteId": "fn_9",
        "structuredCondition": "hematology.components == [\"CBC\", \"differentials\"]",
        "appliesToActivityIds": [
          "Hematology"
        ],
        "sourceText": "i. Hematology includes CBC and differentials"
      },
      {
        "id": "fn_cond_9",
        "conditionType": "general",
        "text": "k. Serum chemistry includes standard metabolic panel",
        "footnoteId": "fn_11",
        "structuredCondition": "chemistry.components == [\"standard metabolic panel\"]",
        "appliesToActivityIds": [
          "Serum chemistry"
        ],
        "sourceText": "k. Serum chemistry includes standard metabolic panel"
      },
      {
        "id": "fn_cond_10",
        "conditionType": "general",
        "text": "l. Urinalysis includes dipstick and microscopy if needed",
        "footnoteId": "fn_12",
        "structuredCondition": "urinalysis.components == [\"dipstick\", \"microscopy_if_needed\"]",
        "appliesToActivityIds": [
          "Urinalysis"
        ],
        "sourceText": "l. Urinalysis includes dipstick and microscopy if needed"
      },
      {
        "id": "fn_cond_11",
        "conditionType": "procedure_fasting",
        "text": "m. Lipid panel requires 8-hour fasting",
        "footnoteId": "fn_13",
        "structuredCondition": "subject.fastingHours >= 8",
        "sourceText": "m. Lipid panel requires 8-hour fasting"
      },
      {
        "id": "fn_cond_12",
        "conditionType": "general",
        "text": "n. Pregnancy testing for females of childbearing potential",
        "footnoteId": "fn_14",
        "sourceText": "n. Pregnancy testing for females of childbearing potential"
      },
      {
        "id": "fn_cond_13",
        "conditionType": "general",
        "text": "o. Urine pregnancy test conducted at site",
        "footnoteId": "fn_15",
        "sourceText": "o. Urine pregnancy test conducted at site"
      },
      {
        "id": "fn_cond_14",
        "conditionType": "general",
        "text": "p. HIV, Hepatitis, and Viral screening requirements",
        "footnoteId": "fn_16",
        "sourceText": "p. HIV, Hepatitis, and Viral screening requirements"
      },
      {
        "id": "fn_cond_15",
        "conditionType": "general",
        "text": "v. Investigational Treatment Administration details",
        "footnoteId": "fn_18",
        "sourceText": "v. Investigational Treatment Administration details"
      },
      {
        "id": "fn_cond_16",
        "conditionType": "general",
        "text": "x. NRS assessed via eDiary",
        "footnoteId": "fn_20",
        "sourceText": "x. NRS assessed via eDiary"
      },
      {
        "id": "fn_cond_17",
        "conditionType": "general",
        "text": "y. DLQI/CDLQI age-specific versions",
        "footnoteId": "fn_21",
        "sourceText": "y. DLQI/CDLQI age-specific versions"
      },
      {
        "id": "fn_cond_18",
        "conditionType": "frequency_daily",
        "text": "z. PSAAD daily completion requirements",
        "footnoteId": "fn_22",
        "sourceText": "z. PSAAD daily completion requirements"
      },
      {
        "id": "fn_cond_19",
        "conditionType": "general",
        "text": "aa. EQ-5D age-specific versions",
        "footnoteId": "fn_23",
        "sourceText": "aa. EQ-5D age-specific versions"
      },
      {
        "id": "fn_cond_20",
        "conditionType": "general",
        "text": "bb. SF-36v2 for adults only",
        "footnoteId": "fn_24",
        "sourceText": "bb. SF-36v2 for adults only"
      },
      {
        "id": "fn_cond_21",
        "conditionType": "general",
        "text": "cc. FACIT-F age-specific versions",
        "footnoteId": "fn_25",
        "sourceText": "cc. FACIT-F age-specific versions"
      },
      {
        "id": "fn_cond_22",
        "conditionType": "general",
        "text": "ee. Flare assessment criteria",
        "footnoteId": "fn_26",
        "sourceText": "ee. Flare assessment criteria"
      },
      {
        "id": "fn_cond_23",
        "conditionType": "general",
        "text": "ff. Contraception check for relevant subjects",
        "footnoteId": "fn_27",
        "sourceText": "ff. Contraception check for relevant subjects"
      },
      {
        "id": "fn_cond_24",
        "conditionType": "general",
        "text": "gg. Baseline viral screen samples",
        "footnoteId": "fn_28",
        "sourceText": "gg. Baseline viral screen samples"
      }
    ],
    "endpointAlgorithms": [
      {
        "id": "ep_1",
        "name": "Primary: Efficacy of PF-04965842",
        "endpointType": "Primary",
        "inputs": [
          "PF-04965842",
          "Placebo",
          "Atopic Dermatitis severity scores"
        ],
        "timeWindow": {
          "reference": "Randomization (Week 12)",
          "duration": "From Week 12 to End of Study"
        },
        "algorithm": "Comparison of efficacy between PF-04965842 and placebo in a randomized withdrawal design",
        "successCriteria": "Statistically significant maintenance of response or reduction in flares compared to placebo",
        "sourceText": "A PHASE 3 RANDOMIZED WITHDRAWAL, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY INVESTIGATING THE EFFICACY AND SAFETY OF PF-04965842 IN SUBJECTS AGED 12 YEARS AND OVER, WITH MODERATE TO SEVERE A"
      },
      {
        "id": "ep_2",
        "name": "Key Secondary Endpoint",
        "endpointType": "Secondary",
        "inputs": [
          "Clinical outcome measures"
        ],
        "timeWindow": {
          "reference": "Baseline/Week 12",
          "duration": "Study duration"
        },
        "algorithm": "Defined in the Statistical Analysis Plan (SAP) as per Amendment 2",
        "successCriteria": "Not explicitly defined in the provided summary text",
        "sourceText": "Clarified the primary and secondary objectives and endpoints. Addition of Key Secondary endpoint."
      },
      {
        "id": "ep_3",
        "name": "Safety: Columbia Suicide Severity Rating Scale (C-SSRS)",
        "endpointType": "Secondary",
        "inputs": [
          "C-SSRS score"
        ],
        "timeWindow": {
          "reference": "Scheduled visits",
          "duration": "Run-in, Blinded treatment, and Rescue weeks 0, 8, 12, 16, EOT/ET, and EOS"
        },
        "algorithm": "Occurrence of suicidal ideation or behavior as reported on the C-SSRS scale",
        "successCriteria": "Absence of new or worsening suicidal ideation/behavior",
        "sourceText": "The Columbia Suicide Severity Rating Scale (C-SSRS) will be administered to all ongoing subjects at all remaining scheduled visits... to align with new cross-program processes."
      },
      {
        "id": "ep_4",
        "name": "Safety: Hepatitis B Reactivation (Regional - China/Taiwan)",
        "endpointType": "Secondary",
        "inputs": [
          "HBV DNA",
          "HBsAg",
          "HBcAb",
          "HBsAb"
        ],
        "timeWindow": {
          "reference": "Screening and Treatment",
          "duration": "Weeks 12, 28, 40, 52, and Rescue Week 12"
        },
        "algorithm": "HBV DNA > Lower Limit of Quantification (LLQ)",
        "successCriteria": "HBV DNA remains below LLQ; a single result above LLQ requires permanent discontinuation",
        "sourceText": "A single HBV DNA test result above the LLQ requires immediate and permanent discontinuation from treatment."
      }
    ],
    "derivedVariables": [
      {
        "id": "dv_1",
        "name": "Change from Baseline in C-SSRS",
        "variableType": "ChangeFromBaseline",
        "sourceVariables": [
          "C-SSRS Score"
        ],
        "derivationRule": "Post-baseline score - Baseline score",
        "baselineDefinition": "Last assessment prior to the start of the Open-Label Run-In period",
        "baselineVisit": "Screening/Run-In Week 0",
        "analysisWindow": "Run-In, Blinded Treatment, and Rescue Weeks 0, 8, 12, 16, EOT/ET, EOS",
        "imputationRule": "Not specified in provided text",
        "unit": "Score"
      },
      {
        "id": "dv_2",
        "name": "HBV DNA Status",
        "variableType": "Categorical",
        "sourceVariables": [
          "HBV DNA"
        ],
        "derivationRule": "If HBV DNA > LLQ then 'Positive/Above LLQ' else 'Negative/Below LLQ'",
        "baselineDefinition": "Reflex testing at Screening for HBsAg negative, HBcAb positive, and HBsAb positive subjects",
        "baselineVisit": "Screening",
        "analysisWindow": "Weeks 12, 28, 40, 52, Rescue Week 12, and ET",
        "imputationRule": "Not specified",
        "unit": "IU/mL"
      }
    ],
    "stateMachine": {
      "id": "sm_1",
      "initialState": "Screening",
      "terminalStates": [
        "Early Termination",
        "Completed"
      ],
      "states": [
        "Screening",
        "Open Label Run In",
        "Randomized Blinded Treatment",
        "End Of Treatment",
        "End Of Study",
        "Early Termination"
      ],
      "transitions": [
        {
          "fromState": "Screening",
          "toState": "Open Label Run In",
          "trigger": "Progress to Open Label Run In"
        },
        {
          "fromState": "Open Label Run In",
          "toState": "Randomized Blinded Treatment",
          "trigger": "Progress to Randomized Blinded Treatment"
        },
        {
          "fromState": "Randomized Blinded Treatment",
          "toState": "End Of Treatment",
          "trigger": "Progress to End Of Treatment"
        },
        {
          "fromState": "End Of Treatment",
          "toState": "End Of Study",
          "trigger": "Progress to End Of Study"
        },
        {
          "fromState": "Randomized Blinded Treatment",
          "toState": "Early Termination",
          "trigger": "Subject exits to Early Termination"
        },
        {
          "fromState": "End Of Treatment",
          "toState": "Early Termination",
          "trigger": "Subject exits to Early Termination"
        }
      ],
      "epochIds": {
        "Screening": "SCREENING",
        "Open Label Run In": "OPEN_LABEL_RUN_IN",
        "Randomized Blinded Treatment": "RANDOMIZED_BLINDED_TREATMENT",
        "End Of Treatment": "END_OF_TREATMENT",
        "End Of Study": "END_OF_STUDY",
        "Early Termination": "EARLY_TERMINATION"
      }
    },
    "dosingRegimens": [
      {
        "id": "dosing_llm_1",
        "treatmentName": "PF-04965842",
        "frequency": "QD",
        "route": "Oral",
        "startDay": 1,
        "durationDescription": "Not explicitly stated in provided text",
        "doseModifications": [
          "Subjects that discontinue study treatment will remain in the study and must have their end of treatment visit within 1 week after their last dose"
        ]
      }
    ],
    "visitWindows": [
      {
        "id": "visit_1",
        "visitName": "Visit 1",
        "targetDay": null,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": true,
        "visitNumber": 1,
        "sourceText": "6. 1. Visit 1, Scree ni n g ....................................................................................................7 0 6. 2. R u n -In I n d ucti o n Treat me nt Peri o d ................"
      },
      {
        "id": "visit_2",
        "visitName": "Visit 2",
        "targetDay": null,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": true,
        "visitNumber": 2,
        "sourceText": "6. 2. 1. Visit 2, Da y 1/ Wee k 0 ( Baseli ne)...............................................................7 2 6. 2. 2. Visit 3, Da y 8/ Wee k 1 (1 da y )..........................................."
      },
      {
        "id": "visit_3",
        "visitName": "Visit 3",
        "targetDay": null,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": true,
        "visitNumber": 3,
        "sourceText": "6. 2. 2. Visit 3, Da y 8/ Wee k 1 (1 da y ).................................................................. 7 4 6. 2. 3. Visit 4, Da y 1 5/ Wee k 2 (1 da y )......................................."
      },
      {
        "id": "visit_4",
        "visitName": "Visit 4",
        "targetDay": null,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": true,
        "visitNumber": 4,
        "sourceText": "6. 2. 3. Visit 4, Da y 1 5/ Wee k 2 (1 da y )................................................................ 7 4 6. 2. 4. Visit 5, Da y 2 9/ Wee k 4 (2 da y s) ....................................."
      },
      {
        "id": "visit_5",
        "visitName": "Visit 5",
        "targetDay": null,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": true,
        "visitNumber": 5,
        "sourceText": "6. 2. 4. Visit 5, Da y 2 9/ Wee k 4 (2 da y s) ..............................................................7 5 6. 2. 5. Visit 6, Da y 4 3/ Wee k 6 (3 da y s) ......................................"
      },
      {
        "id": "visit_6",
        "visitName": "Visit 6",
        "targetDay": null,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": true,
        "visitNumber": 6,
        "sourceText": "6. 2. 5. Visit 6, Da y 4 3/ Wee k 6 (3 da y s) ..............................................................7 6 6. 2. 6. Visit 7, Da y 5 7/ Wee k 8 (3 da y s) ......................................"
      },
      {
        "id": "visit_7",
        "visitName": "Visit 7",
        "targetDay": null,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": true,
        "visitNumber": 7,
        "sourceText": "6. 2. 6. Visit 7, Da y 5 7/ Wee k 8 (3 da y s) ..............................................................7 7 6. 3. D o u ble- Bli n d Mai nte na nc e Treat me nt Peri o d ........................"
      },
      {
        "id": "visit_8",
        "visitName": "Visit 8",
        "targetDay": null,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": true,
        "visitNumber": 8,
        "sourceText": "6. 3. 1. Visit 8, Da y 8 5/ Wee k 1 2 (3 da y s) Ra n d o mizati o n i nt o Mai nte na nce Treat me nt ................................................................................................"
      },
      {
        "id": "visit_9",
        "visitName": "Visit 9",
        "targetDay": null,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": true,
        "visitNumber": 9,
        "sourceText": "6. 3. 2. Visit 9, Da y 1 1 3/ Wee k 1 6 (3 da y s) ..........................................................8 0 6. 3. 3. Visit 1 0, Da y 1 9 7/ Wee k 2 8 (7 da y s) ................................"
      },
      {
        "id": "visit_10",
        "visitName": "Early Termination",
        "targetDay": null,
        "windowBefore": 0,
        "windowAfter": 0,
        "isRequired": true,
        "visitNumber": 10,
        "sourceText": "7. 3. Safet y Assess me nts ................................................................................................. 9 9 7. 3. 1. V itals Si g ns.............................................."
      },
      {
        "id": "visit_llm_1",
        "visitName": "Screening",
        "targetDay": null,
        "windowBefore": null,
        "windowAfter": null,
        "isRequired": true,
        "visitNumber": 1,
        "epoch": "Screening"
      },
      {
        "id": "visit_llm_13",
        "visitName": "4 Weeks Post EOT/ET - End of Study",
        "targetDay": null,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": true,
        "visitNumber": 13,
        "epoch": "Follow-up Visit"
      },
      {
        "id": "visit_llm_8",
        "visitName": "Rescue Treatment - Visit 8, Follow-up Visit and End of Study",
        "targetDay": null,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": false,
        "visitNumber": 8,
        "epoch": "Rescue Treatment Period"
      },
      {
        "id": "visit_llm_2",
        "visitName": "Day 1/ Week 0 (Baseline)",
        "targetDay": 1,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": true,
        "visitNumber": 2,
        "targetWeek": 0,
        "epoch": "Run-In Induction Treatment Period"
      },
      {
        "id": "visit_llm_3",
        "visitName": "Day 8/ Week 1",
        "targetDay": 8,
        "windowBefore": 1,
        "windowAfter": 1,
        "isRequired": true,
        "visitNumber": 3,
        "targetWeek": 1,
        "epoch": "Run-In Induction Treatment Period"
      },
      {
        "id": "visit_llm_4",
        "visitName": "Day 15/ Week 2",
        "targetDay": 15,
        "windowBefore": 1,
        "windowAfter": 1,
        "isRequired": true,
        "visitNumber": 4,
        "targetWeek": 2,
        "epoch": "Run-In Induction Treatment Period"
      },
      {
        "id": "visit_11",
        "visitName": "Week 4",
        "targetDay": 22,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": true,
        "visitNumber": 17,
        "targetWeek": 4,
        "sourceText": "pr ofile e val uati o n at t he f oll o wi n g Resc ue Vi sits: Da y 1, Week 4, Wee k 1 2 a n d E O S visits. i. Uri ne pre g na nc y test m ust be perf or me d a t e ver y site visit pri or t o d osi"
      },
      {
        "id": "visit_llm_5",
        "visitName": "Day 29/ Week 4",
        "targetDay": 29,
        "windowBefore": 2,
        "windowAfter": 2,
        "isRequired": true,
        "visitNumber": 5,
        "targetWeek": 4,
        "epoch": "Run-In Induction Treatment Period"
      },
      {
        "id": "visit_llm_6",
        "visitName": "Day 43/ Week 6",
        "targetDay": 43,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": true,
        "visitNumber": 6,
        "targetWeek": 6,
        "epoch": "Run-In Induction Treatment Period"
      },
      {
        "id": "visit_llm_7",
        "visitName": "Day 57/ Week 8",
        "targetDay": 57,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": true,
        "visitNumber": 7,
        "targetWeek": 8,
        "epoch": "Run-In Induction Treatment Period"
      },
      {
        "id": "visit_llm_8",
        "visitName": "Day 85/ Week 12 (Randomization)",
        "targetDay": 85,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": true,
        "visitNumber": 8,
        "targetWeek": 12,
        "epoch": "Double-Blind Maintenance Treatment Period"
      },
      {
        "id": "visit_llm_9",
        "visitName": "Day 113/ Week 16",
        "targetDay": 113,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": true,
        "visitNumber": 9,
        "targetWeek": 16,
        "epoch": "Double-Blind Maintenance Treatment Period"
      },
      {
        "id": "visit_llm_10",
        "visitName": "Day 197/ Week 28",
        "targetDay": 197,
        "windowBefore": 7,
        "windowAfter": 7,
        "isRequired": true,
        "visitNumber": 10,
        "targetWeek": 28,
        "epoch": "Double-Blind Maintenance Treatment Period"
      },
      {
        "id": "visit_llm_11",
        "visitName": "Day 281/ Week 40",
        "targetDay": 281,
        "windowBefore": 7,
        "windowAfter": 7,
        "isRequired": true,
        "visitNumber": 11,
        "targetWeek": 40,
        "epoch": "Double-Blind Maintenance Treatment Period"
      },
      {
        "id": "visit_llm_12",
        "visitName": "Day 365/ Week 52 (EOT/ET)",
        "targetDay": 365,
        "windowBefore": 3,
        "windowAfter": 3,
        "isRequired": true,
        "visitNumber": 12,
        "targetWeek": 52,
        "epoch": "Double-Blind Maintenance Treatment Period"
      }
    ]
  }
}